Skip to content

Net Income at other companies

Danaher logo
DanaherDHR
$1.03B+7.9%
Agilent Technologies logo
Agilent TechnologiesA
$339M+57.7%
Quest Diagnostics logo
Quest DiagnosticsDGX
$252M+14.5%
Abbott logo
AbbottABT
$1.08B-18.7%
Elanco Animal Health Inc. logo
Elanco Animal Health Inc.ELAN
$57M-14.9%
Ecolab logo
EcolabECL
$432.6M+7.5%

Other financials

Income statement

See full
Revenue$1.1B+14.3%
Gross profit$722.7M+15.9%
Operating income$362.6M+14.5%
EPS (diluted)$3.47+17.2%

Balance sheet

See full
Cash & equivalents$200.5M+22.3%
Total debt$575.5M-22.2%
Total equity$1.6B+7.5%
Total assets$3.4B+5.3%

Cash flow

See full
Operating cash flow$266.2M+11.9%
CapEx$32.0M+6.5%
Free cash flow$234.3M+12.7%

Valuation

See full
Market cap$43.78B+3.9%
Enterprise value$44.15B+3.4%
P/E40×-7.1×
P/S9.9×-0.9×

Profitability

See full
Gross margin62.1%+0.8pp
Operating margin31.6%+2.5pp
Net margin24.6%+1.9pp
FCF margin24.4%+2.8pp

Returns & leverage

See full
Return on equity72.9%+13.6pp
Debt / equity0.4×-0.1×
Current ratio1.1×0.0×

Where this comes from

Reported directly by Idexx Laboratories in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Idexx Laboratories's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Idexx Laboratories's net income?
Idexx Laboratories (IDXX) reported net income of $278.45M in Q1 2026.
How has Idexx Laboratories's net income changed year-over-year?
Idexx Laboratories's net income increased by 14.7% year-over-year, from $242.68M to $278.45M.
What is the long-term trend for Idexx Laboratories's net income?
Over 4 years (2021 to 2025), Idexx Laboratories's net income has grown at a 9.2% compound annual growth rate (CAGR), from $744.85M to $1.06B.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.